For patients with cholangiocarcinoma, or bile duct cancer, the first line of treatment often includes standard cancer treatments, such as surgery, chemotherapy and radiation therapy. However, in the last few years, oncologists have found that there may be a better option for patients whose cancer has a mutation in the fibroblast growth factor receptor (FGFR).
FGFR inhibitors, in combination with standard treatments,...
The human immune system is constantly attacking damaged cells that might turn into cancer, thus protecting us from these cells growing out...
You may have heard someone with multiple myeloma mention the possibility of BCMA-targeted therapy and wondered what BCMA means and why it...
Chimeric antigen receptor (CAR) T cell therapy has been an amazing advance for treating blood cancers like leukemia, lymphoma and multiple myeloma. Now, it is showing promise for solid tumors — from lung cancer to kidney cancer to bone cancer — as well. “We’re trying to adopt the same strategy that has worked in hematologic malignancies, where CAR T cell treatments have greatly increased survival,” says Samer Srour, MB ChB, assistant...
